Boehringer Ingelheim and SoundTalks end their partnership, but what does this mean for pig farmers? Find out about the future ...

Boehringer Ingelheim & LEO Pharma partner to commercialize and further develop Spevigo: Ingelheim, Germany Wednesday, July 16, 2025, 15:00 Hrs [IST] Boehringer Ingelheim, a biopha ...

Boehringer Ingelheim set to receive EUR 90 million as upfront payment, along with milestone payments and tiered royalties.

Pioneer in RNA research who gave children with SMA a future Sabine Löwer Communications Boehringer Ingelheim St ...

In a significant push to address one of the Philippines’ most pressing but underrecognized public health issues, the German-Philippine Chamber of Commerce and Industry (GPCCI), the German Embassy ...

BI 1815368, a potential oral treatment to improve vision in patients with diabetic macular edema, is being investigated in a ...

LEO Pharma acquires global rights to Spevigo for $105M, boosting its dermatology pipeline and expanding access for patients ...

Zest customers spending £70m per month on employee benefits packages Employee benefits technology provider Zest has seen a spike of 8% in monthly spending on reward packages by customers over the last ...

Steatotic liver disease often progresses asymptomatically, with the risk of advancing to cirrhosis and liver cancer. Early detection of advanced liver disease through screening presents an opportunity ...

Virtual wards, extra health care appointments and a huge boost in vaccinations are among the keys to improving healthcare across Hampshire over the next ten years, health bosses have said.

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.